Brief: Painreform Completes First Part Of Phase 3 Clinical Trial In Patients Undergoing Bunionectomy Surgery
28/03/2023 14:37
March 28 (Reuters) - PainReform Ltd PRFX.O :
* PAINREFORM COMPLETES FIRST PART OF PHASE 3 CLINICAL
TRIAL IN
PATIENTS UNDERGOING BUNIONECTOMY SURGERY
* PAINREFORM LTD - INITIAL PHARMACOKINETIC DATA ON FIRST 15
PATIENTS IS EXPECTED IN MAY 2023
Source text for Eikon: ID:nGNXbF1Q2R
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PRF Technologies
See all newsBrief: Prf Technologies S.H.N. Financial Investments Seeks Special General Meeting At Prf Technologies To Remove Directors, Appoint Three S.H.N. Nominees
U.S. STOCKS ON THE MOVE-Bumble, Tempus AI, TD Synnex
U.S. STOCKS ON THE MOVE-Bio-Techne, IBM, Apple
PRF Technologies rises as animal study shows pain drug matches approved rival
U.S. STOCKS ON THE MOVE-Wendy's, Canadian Solar, Bio-Techne